Accuracy of health-related quality of life in identifying systolic dysfunction in patients with Chagas cardiomyopathy.
Chagas cardiomyopathy
echocardiography
left ventricular dysfunction
quality of life
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
pubmed:
18
4
2021
medline:
17
8
2021
entrez:
17
4
2021
Statut:
ppublish
Résumé
Systolic dysfunction is a well-established marker of mortality in patients with Chagas cardiomyopathy (CC). However, its diagnosis is expensive and useful tools for screening these patients are required. The evaluation of the health-related quality of life (HRQoL) detects the patient's perception of the disease's impact. However, its accuracy in identifying patients with CC and systolic dysfunction is unknown. The study aimed to verify the sensitivity, specificity and predictive values of the physical and mental components related to HRQoL in identifying patients with CC and systolic dysfunction. 75 patients with CC, aged 49 (95% confidence interval: 47-51) years, were evaluated by echocardiography and Short-Form of Health Survey (SF-36) questionnaire. Systolic dysfunction was defined by left ventricular ejection fraction <52% for men and <54% for women and left ventricular diastolic diameter >55 mm. Most patients (73%) had systolic dysfunction, with lower HRQoL values in the physical functioning, physical role functioning and general health perceptions domains and in the physical component summary. The accuracy of identifying patients with systolic dysfunction by the scores of physical components was 73% and 62% of mental components. The optimal cut-off point was 46 for physical and 54 for mental components, with respective positive predictive values of 91% and 80%. The evaluation of the HRQoL by the SF-36, a low-cost instrument, can be useful in identifying patients with systolic dysfunction, assisting in the screening and risk stratification of patients.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
936-942Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Lidani KCF, Andrade FA, Bavia L et al. Chagas disease: from discovery to a worldwide health problem. Front Public Health 2019: 7: 166.
WHO. Chagas disease (American trypanosomiasis) [Internet]. Geneva, Switzerland: WHO. 2020. https://www.who.int/news-room/q-a-detail/chagas-disease
Antinori S, Galimberti L, Bianco R, Grande R, Galli M, Corbellino M. Chagas disease in Europe: a review for the internist in the globalized world. Eur J Intern Med 2017: 43: 6-15.
Requena-Méndez A, Aldasoro E, de Lazzari E et al. Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis 2015: 9: 1-15.
Jackson Y, Pinto A, Pett S. Chagas disease in Australia and New Zealand: risks and needs for public health interventions. Trop Med Int Health 2014: 19: 212-218.
Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL. Council on Chagas Disease of the Interamerican Society of C. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol 2013: 62: 767-776.
Bestetti RB, Muccillo G. Clinical course of Chagas’ heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 1997: 60: 187-193.
Botoni FA, Ribeiro AL, Marinho CC, Lima MM, Nunes Mdo C, Rocha MO. Treatment of Chagas cardiomyopathy. Biomed Res Int 2013: 2013: 849504.
Nunes MCP, Beaton A, Acquatella H et al. Chagas Cardiomyopathy: an update of current clinical knowledge and management: a Scientific Statement From the American Heart Association. Circulation 2018: 138: e169-e209.
Nunes MC, Carmo AA, Rocha MO, Ribeiro AL. Mortality prediction in Chagas heart disease. Expert Rev Cardiovasc Ther 2012: 10: 1173-1184.
Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 2012: 9: 576-589.
Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007: 115: 1101-1108.
Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007: 5: 727-743.
Del Buono MG, Arena R, Borlaug BA et al. Exercise intolerance in patients with heart failure: JACC State-of-the-Art Review. J Am Coll Cardiol 2019: 73: 2209-2225.
Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001: 322: 1357-1360.
Oliveira BG, Velasquez-Melendez G, Rincon LG, Ciconelli RM, Sousa LA, Ribeiro AL. Health-related quality of life in Brazilian pacemaker patients. Pacing Clin Electrophysiol 2008: 31: 1178-1183.
Pokharel Y, Khariton Y, Tang Y et al. Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 Randomized Clinical Trials. JAMA Cardiol 2017: 2: 1315-1321.
Sousa GR, Costa HS, Souza AC, Nunes MCP, Lima MMO, Da Costa Rocha MO. Health-related quality of life in patients with chagas disease: a review of the evidence. Rev Soc Bras Med Trop 2015: 48: 121-128.
Chambela MC, Mediano MFF, Ferreira RR et al. Correlation of 6-min walk test with left ventricular function and quality of life in heart failure due to Chagas disease. Trop Med Int Health 2017: 22: 1314-1321.
Costa HS, Lima MMO, Figueiredo PHS, Chaves AT, Nunes MCP, da Costa Rocha MO. The prognostic value of health-related quality of life in patients with Chagas heart disease. Qual Life Res 2019: 28: 67-72.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013: 310: 2191-2194.
Bossuyt PM, Reitsma JB, Bruns DE et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015: 351: h5527.
Andrade JPD, Marin Neto JA, Paola AAVd et al. I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo. Arq Bras Cardiol 2011: 96: 434-442.
The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Blood Vessels. Boston: Little Brown, 1964.
Lang RM, Badano LP, Mor-Avi V et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015: 28: 1-39.e14.
Ciampi Q, Villari B. Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction. Cardiovasc Ultrasound 2007: 5: 34.
Klaeboe LG, Edvardsen T. Echocardiographic assessment of left ventricular systolic function. J Echocardiogr 2019: 17: 10-16.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey SF-36. I. Conceptual framework and item selection. Med Care 1992: 30: 473-483.
Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Translation to Brazilian Portuguese and validation of the generic questionnaire to assessment quality of life - the SF-36 (SF-36 Brazil). Rev Bras Reumatol 1997: 39: 143-150.
Dourado KC, Bestetti RB, Cordeiro JA, Theodoropoulos TA. Assessment of quality of life in patients with chronic heart failure secondary to Chagas’ cardiomyopathy. Int J Cardiol 2006: 108: 412-413.
Vieira FC, de Melo Marinho PÉ, Brandão DC, e Silva OB. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas Cardiomyopathy. Physiother Res Int 2014: 19: 8-15.
Oliveira BG, Abreu MNS, Abreu CDG, Rocha MOdC, Ribeiro AL. Health-related quality of life in patients with Chagas disease. Rev Soc Bras Med Trop 2011: 44: 150-156.
Walsh TL, Homa K, Hanscom B, Lurie J, Sepulveda MG, Abdu W. Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey. Spine J 2006: 6: 316-320.
Matcham F, Norton S, Steer S, Hotopf M. Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis. BMC Musculoskelet Disord 2016: 23: 224.
Tavella R, Air T, Tucker G, Adams R, Beltrame JF, Schrader G. Using the Short Form-36 mental summary score as an indicator of depressive symptoms in patients with coronary heart disease. Qual Life Res 2010: 19: 1105-1113.
de Alencar MC, Rocha MO, Lima MM et al. Heart rate recovery in asymptomatic patients with Chagas disease. PLoS One 2014: 9: e100753.